Download PDF
Thromb Haemost 2020; 120(09): 1257-1269
DOI: 10.1055/s-0040-1713890
Coagulation and Fibrinolysis

A Pathological Clarification of Sepsis-Associated Disseminated Intravascular Coagulation Based on Comprehensive Coagulation and Fibrinolysis Function

Tomoko Onishi
1   Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan
,
Keiji Nogami
1   Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan
,
Takashi Ishihara
1   Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan
,
Satoki Inoue
2   Department of Anesthesiology, Nara Medical University, Kashihara, Nara, Japan
,
Masahiko Kawaguchi
2   Department of Anesthesiology, Nara Medical University, Kashihara, Nara, Japan
,
Kenji Nishio
3   Department of General Medicine, Nara Medical University, Kashihara, Nara, Japan
,
Hidetada Fukushima
4   Department of Emergency and Critical Care Medicine, Nara Medical University, Kashihara, Nara, Japan
,
Hiroshi Kobayashi
5   Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara, Japan
,
Itsuto Amano
6   Second Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
,
Toshiya Nishikubo
7   Neonatal Intensive Care Unit, Nara Medical University, Kashihara, Nara, Japan
,
Masaharu Yamasaki
8   Division of Clinical Laboratory, Nara Medical University, Kashihara, Nara, Japan
,
Masato Kasahara
9   Clinical Research Center, Nara Medical University, Kashihara, Nara, Japan
,
Midori Shima
1   Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan
› Author Affiliations Funding This work was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) provided to T.O. (Grant No. 18K15726) and K.N. (Grant No. 18K07885) and a Special Project Grant at Nara Medical University.
› Further Information
    Permissions and Reprints

Abstract

Background The functional dynamics of coagulation and fibrinolysis in patients with disseminated intravascular coagulation (DIC) vary due to the pathology and severity of various underlying diseases. Conventional measurements of hemostasis such as thrombin–antithrombin complex, plasmin-α2-plasmin-inhibitor complex, and fibrinogen-fibrin degradation products may not always reflect critical pathophysiologic mechanisms in DIC. This article aims to clarify the pathology of sepsis-associated DIC using assessment of comprehensive coagulation and fibrinolysis.

Methods Plasma samples were obtained from 57 patients with sepsis-associated DIC at the time of initial diagnosis. Hemostasis parameters were quantified by clot-fibrinolysis waveform analysis (CFWA) and thrombin/plasmin generation assays (T/P-GA). The results were expressed as ratios relative to normal plasma.

Results CFWA demonstrated that the maximum coagulation velocity (|min1|) ratio modestly increased to median 1.40 (min − max: 0.10 − 2.60) but the maximum fibrinolytic velocity (|FL-min1|) ratio decreased to 0.61 (0 − 1.19). T/P-GA indicated that the peak thrombin (Th-Peak) ratio moderately decreased to 0.71 (0.22 − 1.20), whereas the peak plasmin (Plm-Peak) ratio substantially decreased to 0.35 (0.02 − 1.43). Statistical comparisons identified a correlation between |min1| and Th-Peak ratios (ρ = 0.55, p < 0.001), together with a strong correlation between |FL-min1| and Plm-Peak ratios (ρ = 0.71, p < 0.001), suggesting that CFWA reflected the balance between thrombin and plasmin generation. With |min1| and |FL-min1| ratios, DIC was classified as follows: coagulation-predominant, coagulation/fibrinolysis-balanced, fibrinolysis-predominant, and consumption-impaired coagulation. The majority of patients in our cohort (80.7%) were coagulation-predominant.

Conclusion A pathological clarification of sepsis-associated DIC based on the assessment of coagulation and fibrinolysis dynamics may be useful for the hemostatic monitoring and management of optimal treatment in these individuals.

Keywords

disseminated intravascular coagulation - sepsis - coagulation - fibrinolysis - monitoring

Authors' Contributions

T.O. designed the research, collected the samples, performed experiments, interpreted the data, and drafted the manuscript; K.N. designed the research, interpreted the data, drafted the manuscript, edited the manuscript, and approved the final version for publication; T.I. designed the research, interpreted the data, and supported the experimental studies; M.K., K.N., H.F., H.K., I.A., and N.T. all provided clinical support for this study; M.Y. performed the laboratory examinations; and M.K. and M.S. supervised the study.


Supplementary Material



Publication History

Received: 27 February 2020

Accepted: 26 May 2020

Article published online:
17 July 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care 2014; 2 (01) 20
    CrossrefPubMedGoogle Scholar
  • 2 Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341 (08) 586-592
    CrossrefPubMedGoogle Scholar
  • 3 Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 2010; 38 (Suppl. 02) S35-S42
    CrossrefPubMedGoogle Scholar
  • 4 Wada H, Asakura H, Okamoto K. , et al; Japanese Society of Thrombosis Hemostasis/DIC subcommittee. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thromb Res 2010; 125 (01) 6-11
    CrossrefPubMedGoogle Scholar
  • 5 Gando S, Iba T, Eguchi Y. , et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006; 34 (03) 625-631
    CrossrefPubMedGoogle Scholar
  • 6 Levi M, van der Poll T, Schultz M. New insights into pathways that determine the link between infection and thrombosis. Neth J Med 2012; 70 (03) 114-120
    PubMedGoogle Scholar
  • 7 van Gorp EC, Suharti C, ten Cate H. , et al. Review: infectious diseases and coagulation disorders. J Infect Dis 1999; 180 (01) 176-186
    CrossrefPubMedGoogle Scholar
  • 8 Levi M, Schultz M, van der Poll T. Disseminated intravascular coagulation in infectious disease. Semin Thromb Hemost 2010; 36 (04) 367-377
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Voss R, Matthias FR, Borkowski G, Reitz D. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 1990; 75 (01) 99-105
    CrossrefPubMedGoogle Scholar
  • 10 Asakura H, Jokaji H, Saito M. , et al. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coagul Fibrinolysis 1994; 5 (05) 829-832
    CrossrefPubMedGoogle Scholar
  • 11 Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 1990; 33 (02) 90-95
    CrossrefPubMedGoogle Scholar
  • 12 Kario K, Matsuo T, Kodama K, Matsuo M, Yamamoto K, Kobayashi H. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio. Haemostasis 1992; 22 (04) 179-186
    PubMedGoogle Scholar
  • 13 Ilich A, Bokarev I, Key NS. Global assays of fibrinolysis. Int J Lab Hematol 2017; 39 (05) 441-447
    CrossrefPubMedGoogle Scholar
  • 14 Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J 2015; 13: 1
    CrossrefPubMedGoogle Scholar
  • 15 Ito T, Thachil J, Asakura H, Levy JH, Iba T. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential. Crit Care 2019; 23 (01) 280
    CrossrefPubMedGoogle Scholar
  • 16 Nogami K, Matsumoto T, Sasai K, Ogiwara K, Arai N, Shima M. A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders. Br J Haematol 2019; 187 (04) 518-529
    CrossrefPubMedGoogle Scholar
  • 17 Matsumoto T, Nogami K, Shima M. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Thromb Haemost 2013; 110 (04) 761-768
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Yoshizawa H, Nogami K, Matsumoto T. , et al. Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays. Thromb Res 2019; 174: 76-83
    CrossrefPubMedGoogle Scholar
  • 19 Mimms LT, Zampighi G, Nozaki Y, Tanford C, Reynolds JA. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry 1981; 20 (04) 833-840
    CrossrefPubMedGoogle Scholar
  • 20 Asakura H, Takahashi H, Uchiyama T. , et al. Diagnostic criteria for DIC by the Japanese Society on Thrombosis and Hemostasis-2017 edition [in Japanese]. Nihon Kessen Shiketsu Gakkai shi 2017; 28: 369-392
    CrossrefPubMedGoogle Scholar
  • 21 Hemker HC, Willems GM, Béguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56 (01) 9-17
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Vincent JL, Moreno R, Takala J. , et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22 (07) 707-710
    CrossrefPubMedGoogle Scholar
  • 23 Samis JA, Stewart KA, Toh CH, Day A, Downey C, Nesheim ME. Temporal changes in factors associated with neutrophil elastase and coagulation in intensive care patients with a biphasic waveform and disseminated intravascular coagulation. J Thromb Haemost 2004; 2 (09) 1535-1544
    CrossrefPubMedGoogle Scholar
  • 24 Toh CH, Samis J, Downey C. , et al. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002; 100 (07) 2522-2529
    CrossrefPubMedGoogle Scholar
  • 25 Smith EY, Charles LA, Van Cott EM. Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patients. Am J Clin Pathol 2004; 121 (01) 138-141
    CrossrefPubMedGoogle Scholar
  • 26 Hussain N, Hodson D, Marcus R, Baglin T, Luddington R. The biphasic transmittance waveform: an early marker of sepsis in patients with neutropenia. Thromb Haemost 2008; 100 (01) 146-148
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Mair G, Dunhill S, Tiplady C. Prognostic implications of a biphasic waveform for APTT analysis in a district general hospital. Int J Lab Hematol 2008; 30 (06) 467-472
    PubMedGoogle Scholar
  • 28 Suzuki K, Wada H, Matsumoto T. , et al. Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk. Thromb J 2019; 17: 12
    CrossrefPubMedGoogle Scholar
  • 29 Ishihara T, Nogami K, Onishi T. , et al. Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation. Pediatr Int (Roma) 2019; 61 (09) 872-881
    CrossrefPubMedGoogle Scholar
  • 30 Ishihara T, Nogami K, Ochi S. , et al. Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2020; 67 (01) e28016
    CrossrefPubMedGoogle Scholar
  • 31 Ishihara T, Nogami K, Matsumoto T. , et al. Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation. Int J Hematol 2017; 106 (01) 126-134
    CrossrefPubMedGoogle Scholar
  • 32 Shima M, Matsumoto T, Fukuda K. , et al. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost 2002; 87 (03) 436-441
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Matsumoto T, Shima M, Takeyama M. , et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost 2006; 4 (02) 377-384
    CrossrefPubMedGoogle Scholar
  • 34 Hemker HC, Giesen P, Al Dieri R. , et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33 (01) 4-15
    CrossrefPubMedGoogle Scholar
  • 35 Suzuki A, Suzuki N, Kanematsu T. , et al. Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders. Thromb Res 2019; 174: 98-103
    CrossrefPubMedGoogle Scholar
  • 36 Rea CJ, Sorensen B, Ingerslev J, Sørensen B. Fibrinogen: a procoagulant and an anticoagulant. Blood 2011; 118: 384
    CrossrefPubMedGoogle Scholar
  • 37 Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 2012; 34 (01) 43-62
    CrossrefPubMedGoogle Scholar
  • 38 Aota T, Wada H, Yamashita Y. , et al. An evaluation of the modified diagnostic criteria for DIC established by the Japanese Society of Thrombosis and Hemostasis. Clin Appl Thromb Hemost 2017; 23 (06) 579-584
    CrossrefPubMedGoogle Scholar
  • 39 Asakura H, Ontachi Y, Mizutani T. , et al. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med 2001; 29 (06) 1164-1168
    CrossrefPubMedGoogle Scholar
  • 40 Lawrence Ng CK, Tan CW, Mcvin Cheen HH. , et al. APTT-based clot waveform analysis in various infections. EHA Library 2018; 215813: PS1530
    PubMedGoogle Scholar